ICTA is an international leading CRO providing a strategic and operational expertise in the design and management of Early and Late Phase clinical studies, Early Access and Compassionate Use Programs.
Over the last 35 years, ICTA’s skilled international resources in Europe and USA have been providing full-service solutions or stand-alone services supporting the development of chemicals, biologics, diagnostics and medical devices, across a broad range of therapeutic areas.
Our hallmark lies in our ability to create value through an integrated approach delivered by a cross-functional senior team. Our Medical and Scientific Affairs experts, our seasoned biostatisticians and our experienced clinical project managers, underpinned by an international network of KOLs position us to support regulatory, clinical, and statistical aspects of a wide range of design studies (traditional, adaptive, Bayesian…).
ICTA is also a partner of choice for developing targeted strategies to generate Real World Data that supports the value of your product.
Actively engaged in the development of technology-driven solutions, ICTA provides innovating tools for healthcare professionals and patients (IWRS, e-CRF, ePRO, eDiary) for a safe and secure data collection.
Today ICTA’s R&D consulting unit provides the pharmaceutical, medical device and biotech industries with strategic advice at every stage of drug discovery and development.